Literature DB >> 23886165

miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9.

Jie Jin1, Lin Cai, Zhi-Ming Liu, Xue-Song Zhou.   

Abstract

Deregulated miRNAs participate in osteosarcoma genesis. In this study, the expression of miRNA-218 in human osteosarcomas, adjacent normal tissues and Saos-2 human osteosarcoma cells was first assessed. Then the precise role of miRNA-218 in osteosarcoma cells was investigated. Upon transfection with a miR-218 expression vector, the proliferation of Saos-2 human osteosarcoma cells determined using the ATPlite assay was significantly suppressed, whilw migration of Saos-2 cells detected by wound healing and invasion determined using transwells were dramatically inhibited. Potential target genes of miR-218 were predicted and T-cell lymphoma invasion and metastasis 1 (TIAM1) and matrix metalloproteinase 2 (MMP2) and 9 (MMP9) were identified. This was confirmed by western blotting, which showed that miR-218 expression inhibited TIAM1, MMP2 and MMP9 protein expression. Collectively, these data suggest that miR-218 acts as a tumor suppressor in osteosarcomas by down-regulating TIAM1, MMP2 and MMP9 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23886165     DOI: 10.7314/apjcp.2013.14.6.3681

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  63 in total

1.  Association of MMP-2 expression and prognosis in osteosarcoma patients.

Authors:  Miao Zhang; Xuran Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Tumour Biol       Date:  2013-12-29

3.  miR-218-2 regulates cognitive functions in the hippocampus through complement component 3-dependent modulation of synaptic vesicle release.

Authors:  Si-Yao Lu; Chong-Lei Fu; Liang Liang; Bo Yang; Wei Shen; Qiu-Wen Wang; Yun Chen; Yan-Fen Chen; Yao-Nan Liu; Lin Zhu; Jieqing Zhao; Wei Shi; Shuangli Mi; Jun Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

4.  microRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer.

Authors:  Bei-Bei Tang; Shui-Yi Liu; Y U Zhan; Li-Qing Wei; Xiao-Lu Mao; Jin Wang; L I Li; Zhong-Xin Lu
Journal:  Exp Ther Med       Date:  2015-04-28       Impact factor: 2.447

5.  miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL.

Authors:  Rui Tian; Xianbiao Xie; Ju Han; Canqiao Luo; Bicheng Yong; Huizhi Peng; Jingnan Shen; Tingsheng Peng
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

6.  LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal.

Authors:  Xingchun Gao; Yajing Mi; Yue Ma; Weilin Jin
Journal:  Tumour Biol       Date:  2014-08-16

Review 7.  Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.

Authors:  Dominic Schomberg; Gurwattan Miranpuri; Tyler Duellman; Andrew Crowell; Raghu Vemuganti; Daniel Resnick
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

8.  MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma.

Authors:  Jin Xu; Zengliang Wang; Zhichao Liao; Dong Dai; Xinlong Ma
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

9.  microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.

Authors:  Zhe Liu; Yuanhong Xu; Jin Long; Kejian Guo; Chunlin Ge; Ruixia Du
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

10.  Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro.

Authors:  Rui Gu; Yi-Fu Sun; Min-Fei Wu; Jia-Bei Liu; Jin-Lan Jiang; Shuai-Hua Wang; Xin-Lei Wang; Qiang Guo
Journal:  Tumour Biol       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.